Immunovia AB (publ) (LON:0G8X)
London flag London · Delayed Price · Currency is GBP · Price in SEK
0.418
-0.014 (-3.24%)
At close: Feb 13, 2025

Immunovia AB Market Cap

Immunovia AB has a market cap or net worth of 8.17 million as of February 21, 2025. Its market cap has increased by 38.16% in one year.

Market Cap
8.17M
Enterprise Value
4.25M
Revenue
46.49K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.42

Market Cap Chart

Since December 1, 2015, Immunovia AB's market cap has decreased from 32.41M to 8.17M, a decrease of -74.80%. That is a compound annual growth rate of -13.87%.

History

DateMarket Cap% Change
Feb 21, 20258.17M21.80%
Dec 30, 20246.70M7.32%
Dec 29, 20236.25M-86.82%
Dec 30, 202247.39M-65.91%
Dec 30, 2021139.03M-42.58%
Dec 30, 2020242.14M-16.01%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 181.54B
GSK plc 58.32B
Haleon 35.36B
Smith & Nephew 9.01B
Hikma Pharmaceuticals 5.12B
ConvaTec Group 5.06B
HUTCHMED (China) 2.19B
Genus 1.17B
Market Cap Rankings